Abstract
Obesity has been defined as a “multi-metabolic and hormonal disease state”. Although significant advances have been made in the knowledge of how obesity develops and progresses, our understanding of its etiology and physiopathology is still incomplete.
Calories intake in excess of requirements is stored as fat in the adipose organ. The central nervous system (CNS) and especially the hypothalamus regulates the energy balance receiving afferent signals from the periphery and triggering efferent neuro-hormonal activation aimed at reducing food intake and at increasing energy expenditure. A complex interplay of hormonal substances derived from the gastrointestinal tract with cytokines and other mediators derived from the adipose tissue provide relevant signals to the CNS which regulates satiety and adiposity though secretion of orexigenic or norexigenic peptides.
Multiple etiologic determinants are responsible for obesity development where environmental factors, acting on specific genetic backgrounds, play a prominent role.
On the other hand, the core pathophysiology of obesity consists in the derangement of the central regulation of energy balance with alteration of neuro-chemical and feedback signaling. This in turn produces an inappropriate expansion of the adipose organ with progressive hyper-production of adipokines and especially of inflammatory cytokines. At the systemic level, this translates into atherogenesis and atherosclerosis, hypertension, type 2 diabetes mellitus, increased risk of cardiovascular disease, certain types of tumors and eventually in a reduced life expectancy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Hoyt l, Burnett L. Should obesity be a disease? N.Y. Times. 2014, Feb. 23, SR 12.
Cinti S. The adipose organ at a glance. Dis Model Mech. 2012;5(5):588–94.
Morton GJ, Cummings DE, Baskin DG, Barsh GS, Schwartz MW. Central nervous system control of food intake and body weight. Nature. 2006;443(7109):289–95.
Lenard NR, Berthoud HR. Central and peripheral regulation of food intake and physical activity: pathways and genes. Obesity (Silver Spring). 2008;16 Suppl 3:S11–22.
Owyang C, Heldsinger A. Vagal control of satiety and hormonal regulation of appetite. J Neurogastroenterol Motil. 2011;17(4):338–48.
Stengel A, Taché Y. Interaction between gastric and upper small intestinal hormones in the regulation of hunger and satiety: ghrelin and cholecystokinin take the central stage. Curr Protein Pept Sci. 2011;12(4):293–304.
Rehfeld JF. Incretin physiology beyond glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide: cholecystokinin and gastrin peptides. Acta Physiol (Oxf). 2011;201(4):405–11.
Burger KS, Berner LA. A functional neuroimaging review of obesity, appetitive hormones and ingestive behavior. Physiol Behav. 2014;136:121–7.
Mason BL, Wang Q, Zigman JM. The central nervous system sites mediating the orexigenic actions of ghrelin. Annu Rev Physiol. 2014;76:519–33.
Mietlicki-Baase EG, Hayes MR. Amylin activates distributed CNS nuclei to control energy balance. Physiol Behav. 2014;136:39–46.
Cao H. Adipocytokines in obesity and metabolic disease. J Endocrinol. 2014;220(2):T47–59.
Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr. 2004;92(3):347–55.
Jéquier E. Leptin signaling, adiposity, and energy balance. Ann N Y Acad Sci. 2002;967:379–88.
Mark AL. Selective leptin resistance revisited. Am J Physiol Regul Integr Comp Physiol. 2013;305(6):R566–81.
Turer AT, Scherer PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia. 2012;55(9):2319–26.
Lazar MA. Resistin- and obesity-associated metabolic diseases. Horm Metab Res. 2007;39(10):710–6.
Carnell S, Gibson C, Benson L, Ochner CN, Geliebter A. Neuroimaging and obesity: current knowledge and future directions. Obes Rev. 2012;13(1):43–56.
Del Parigi A, Gautier JF, Chen K, Salbe AD, Ravussin E, Reiman E, Tataranni PA. Neuroimaging and obesity: mapping the brain responses to hunger and satiation in humans using positron emission tomography. Ann N Y Acad Sci. 2002;967:389–97.
Miras AD, le Roux CW. Mechanisms underlying weight loss after bariatric surgery. Nat Rev Gastroenterol Hepatol. 2013;10(10):575–84.
d'Autume C, Musher-Eizenman D, Marinier E, Viarme F, Frelut ML, Isnard P. Eating behaviors and emotional symptoms in childhood obesity: a cross-sectional exploratory study using self-report questionnaires in 63 children and dolescents. Arch Pediatr. 2012;19(8):803–10.
O'Rahilly S, Farooqi IS. Human obesity as a heritable disorder of the central control of energy balance. Int J Obes (Lond). 2008;32 Suppl 7:S55–61.
Rhee KE, Phelan S, McCaffery J. Early determinants of obesity: genetic, epigenetic, and in utero influences. Int J Pediatr. 2012;2012:463850.
Drummond EM, Gibney ER. Epigenetic regulation in obesity. Curr Opin Clin Nutr Metab Care. 2013;16(4):392–7.
Mingrone G, Manco M, Mora ME, Guidone C, Iaconelli A, Gniuli D, Leccesi L, Chiellini C, Ghirlanda G. Influence of maternal obesity on insulin sensitivity and secretion in offspring. Diabetes Care. 2008;31(9):1872–6.
Bray GA. Obesity is a chronic, relapsing neurochemical disease. Int J Obes Relat Metab Disord. 2004;28(1):34–8.
Schäffler A, Müller-Ladner U, Schölmerich J, Büchler C. Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev. 2006;27(5):449–67.
Redinger RN. The pathophysiology of obesity and its clinical manifestations. Gastroenterol Hepatol (N Y). 2007;3(11):856–63.
Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes. 1999;48(6):1270–4.
DeFronzo RA, Tripathy D. Skeletal muscle insulin resistance is the primary defect in type 2 diabetes. Diabetes Care. 2009;32 Suppl 2:S157–63.
Johnson AM, Olefsky JM. The origins and drivers of insulin resistance. Cell. 2013;152(4):673–84.
Mingrone G, Henriksen FL, Greco AV, Krogh LN, Capristo E, Gastaldelli A, Castagneto M, Ferrannini E, Gasbarrini G, Beck-Nielsen H. Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes. 1999;48(6):1258–63.
Mingrone G, Castagneto M. Role of lipids in insulin resistance and type 2 diabetes mellitus development. Nutrition. 1999;15(1):64–6.
Kootte RS, Vrieze A, Holleman F, Dallinga-Thie GM, Zoetendal EG, de Vos WM, Groen AK, Hoekstra JB, Stroes ES, Nieuwdorp M. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab. 2012;14(2):112–20.
Frezza EE, Shebani KO, Robertson J, Wachtel MS. Morbid obesity causes chronic increase of intraabdominal pressure. Dig Dis Sci. 2007;52(4):1038–41.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348(17):1625–38.
Pischon T, Nöthlings U, Boeing H. Obesity and cancer. Proc Nutr Soc. 2008;67(2):128–45.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Mingrone, G., Castagneto, M. (2015). The Pathophysiology of Obesity. In: Lucchese, M., Scopinaro, N. (eds) Minimally Invasive Bariatric and Metabolic Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-15356-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-15356-8_3
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-15355-1
Online ISBN: 978-3-319-15356-8
eBook Packages: MedicineMedicine (R0)